A Study to Evaluate Web-Based Physical Activity Intervention in Children and Adolescents with Newly Diagnosed Acute Lymphoblastic Leukemia in First Remission

Overview

Información sobre este estudio

The primary purpose of this study is to compare the effects of a rewards-and web-based physical activity intervention that includes structured social interaction between participants to the same web-based physical activity intervention that does not include structured social interaction on fitness among children and adolescents following treatment for cancer.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Patient must be ≥ 8 years of age and ≤ 16 years of age at time of enrollment.
  • All cancer cases with an ICD-O histologic behavior code of two "2" (carcinoma in situ) or three "3" (malignant), in remission.
  • Patient must have completed curative chemotherapy within past 12 months at a Childrens Oncology Group (COG) institution.
  • Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2; use Lansky for patients ≤ 16 years of age.
  • At the time of consent, patient or parent/guardian reports less than 420 minutes of moderate to vigorous physical activity over the last week.
  • Patient must have access to a smart phone with Android 4.3 or later or iOS 7.1 or later or computer (laptop/desktop) with a connection to the internet to create an account and be able to sync the Sqord device (accelerometer).
  • Patient and at least one parent/guardian are able to read and write English; at least 1 parent/guardian must be able to read and write English in order to assist the patient with using their Sqord account.
  • All patients and/or their parents or legal guardians must sign a written informed consent.
  • All institutional, FDA, and NCI requirements for human studies must be met.

Exclusion Criteria:

  • Patients with previous hematopoietic stem cell transplant (HSCT).
  • Patients with significant concurrent disease, illness, psychiatric disorder or social issue that would compromise patient safety or compliance with protocol therapy, or interfere with consent, study participation, follow up, or interpretation of study results.
  • Female patients who are pregnant are not eligible; women of childbearing potential require a negative pregnancy test.
  • Female patient who is postmenarcheal and has not agreed to use an effective contraceptive method (including abstinence) for the duration of study participation.
  • Patients with a cognitive, motor, visual or auditory impairment that prevents computer use (e.g., unresolved posterior fossa syndrome) are not eligible.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Wendy Allen-Rhoades, M.D., Ph.D.

Abierto para la inscripción

Contact information:

Rebecca Winslow Rain

(507) 284-2657

WinslowRain.Rebecca@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20506108

Mayo Clinic Footer